ENZON INC
10-Q, EX-27, 2000-11-13
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Previous: ENZON INC, 10-Q, 2000-11-13
Next: APACHE OFFSHORE INVESTMENT PARTNERSHIP, 10-Q, 2000-11-13



<TABLE> <S> <C>


<ARTICLE>                     5
<LEGEND>
This schedule contains summary financial  information  extracted from the Enzon,
Inc. and Subsidiaries  Consolidated  Condensed Balance Sheet as of September 30,
2000 and the Consolidated Condensed Statement of Operations for the three months
ended  September  30, 2000 and is qualified in its entirety by reference to such
financial statements.
</LEGEND>

<S>                             <C>
<PERIOD-TYPE>                   YEAR
<FISCAL-YEAR-END>                         JUN-30-2001
<PERIOD-END>                              SEP-30-2000
<CASH>                                     27,255,389
<SECURITIES>                               30,637,661
<RECEIVABLES>                               5,669,253
<ALLOWANCES>                                        0
<INVENTORY>                                   955,099
<CURRENT-ASSETS>                           68,917,172
<PP&E>                                     12,566,963
<DEPRECIATION>                             10,756,341
<TOTAL-ASSETS>                            135,791,914
<CURRENT-LIABILITIES>                      10,756,340
<BONDS>                                             0
                               0
                                        70
<COMMON>                                      414,421
<OTHER-SE>                                129,431,355
<TOTAL-LIABILITY-AND-EQUITY>              123,924,277
<SALES>                                     4,947,268
<TOTAL-REVENUES>                            5,173,614
<CGS>                                       1,001,188
<TOTAL-COSTS>                               6,712,012
<OTHER-EXPENSES>                                    0
<LOSS-PROVISION>                                    0
<INTEREST-EXPENSE>                                  0
<INCOME-PRETAX>                               582,706
<INCOME-TAX>                                        0
<INCOME-CONTINUING>                           582,706
<DISCONTINUED>                                      0
<EXTRAORDINARY>                                     0
<CHANGES>                                           0
<NET-INCOME>                                  582,706
<EPS-BASIC>                                      0.01
<EPS-DILUTED>                                    0.01


</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission